
The Hollywood Weight Loss Wonder Drug
About this episode
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Need to set up your Slate Plus feed? If you subscribed through Slate.com, check out our FAQ at slate.com/podcastfaqs for easy instructions. Members subscribed via Apple Podcasts get automatic access—no setup required.
Hosted on Acast. See acast.com/privacy for more information.
Get every episode summarized
Each time What Next: TBD | Tech, power, and the future publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from What Next: TBD | Tech, power, and the future

Meta Settled. Is it a "Reckoning?"
What Next: TBD | Tech, power, and the future

A.I. Enshittifies Everything (Still)
What Next: TBD | Tech, power, and the future

Can the Midterms Withstand Prediction Markets?
What Next: TBD | Tech, power, and the future

Are Flock Cameras Watching You?
What Next: TBD | Tech, power, and the future